Advertisement

Journal of Neural Transmission

, Volume 113, Issue 11, pp 1603–1623 | Cite as

Alzheimer 100 – highlights in the history of Alzheimer research

  • K. A. Jellinger
Historical

Summary.

Alzheimer disease, a progressive neurodegenerative disorder of hitherto unknown etiology leading progressively to severe incapacity and death, has become the pandemic of the 21st century. On World Alzheimer Day, September 21, 2006, the 100th anniversary of the first description of the clinical and histological findings in this disorder by A. Alzheimer, was celebrated. This retrospective review of the most important events and advances in Alzheimer research presents its early history in which only clinical and histologic signs of this peculiar disease were described. Electron microscopy, quantitative morphology and modern biochemistry emerging in the second half of the 20th century opened a new era in dementia research with description of the ultrastructure and biochemistry of senile plaques and neurofibrillary tangles, the major disease markers of AD. Advances in the development of clinical, neuropathological, and neuroimaging criteria, modern instruments and algorithms in the diagnosis of the disorder followed, enabling long-term studies and more exact diagnosis of AD and related disorders. Landmark studies were the development of operational criteria for the post mortem diagnosis of AD based on semiquantitative assessment and developmental patterns of its major markers. Basic research gave insight into the molecular genetics and pathophysiology of AD, and, based on the biochemical findings, new pharmacological treatment options were opened. Recently, biological and other surrogate, in particular functional neuroimaging, markers allow an early detection of presymptomatic stages of AD, their risk factors and progression which, in the future, might be prevented or at least slowed by new therapeutic approaches. Since the etiology of AD is hitherto unknown, causative therapies are still not available. The paper discusses future research needs and challenges for developing new diagnostic strategies for early and accurate detection of neurodegenerative processes leading to dementia, better epidemiologic and gender data as well as more insights into the pathogenic cascade of AD and other dementing disorders which will depend on international networks and close cooperation between clinicians, neuroscientists, caregivers, public health institutions, and individual sponsors.

Keywords: Alzheimer disease, dementia, clinical diagnosis, neurobiology, history of Alzheimer research, future perspectives 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aisen, PS 2005The development of anti-amyloid therapy for Alzheimer’s disease: from secretase modulators to polymerisation inhibitorsCNS Drugs19989996PubMedGoogle Scholar
  2. Alexopoulos, P, Grimmer, T, Perneczky, R, Domes, G, Kurz, A 2006Progression to dementia in clinical subtypes of mild cognitive impairmentDement Geriatr Cogn Disord222734PubMedGoogle Scholar
  3. Alf, C, Bancher, C, Benke, T, Berek, K, Bertha, G, Bodner, T, Croy, A, Dal-Bianco, P, Fazekas, F, Fischer, P, Fruhwürth, G, Gatterer, G, Hinterhuber, H, Imarhiagbe, D, Krautgartner, M, Jaksch, A, Jellinger, K, Kalousek, M, Ladurner, G, Leblhuber, F, Lechner, A, Lingg, A, Marksteiner, J, Nakajima, T, Psota, G, Rainer, M, Ransmayr, G, Reisecker, F, Rumpl, E, Schmidt, R, Walch, T, Walter, A, Wancata, J 2004Konsensus-Statement “Demenz” der Österr. Alzheimer GesellschaftMitteilg ÖGN183946Google Scholar
  4. Alf C, Bancher C, Benke K, Berek K, Bodner T, Croy A, Dal-Bianco P, Fischer P, Fruhwürth G, Gatterer G, Grossmann J, Hinterhuber H, Imarhiagbe D, Kapeller P, Krautgartner M, Jaksch A, Jellinger K, Kalousek M, Ladurner G, Leblhuber F, Lechner A, Lingg A, Marksteiner J, Nakajima T, Psota G, Rainer M, Ransmayr G, Reisecker F, Schmidt R, Spatt J, Walch T, Walter A, Wancata J, Winkler A (2006) Konsensusstatement “Demenz” der Österreichischen Alzheimer Gesellschaft – Update 2006 (in press)Google Scholar
  5. Alzheimer, A 1898Neuere Arbeiten über die Dementia senilis und die auf atheromatöser Gefässerkrankung basierenden GehirnkrankheitenMonat Psychiatr Neurol3101115CrossRefGoogle Scholar
  6. Alzheimer, A 1907Über eine eigenartige Erkrankung der HirnrindeAllgem Z Psychiatr-Gerich Med64146148Google Scholar
  7. Alzheimer, A 1911Über eigenartige Krankheitsfälle des späteren AltersZ Gesamte Neurol Psychiatr4356385Google Scholar
  8. Alzheimer Disease & Frontotemporal Dementia Mutation Database (2006) http://www.molgen.ua.ac.be/ADMutations, accessed Sept 6, 2006
  9. Alzheimer’s Disease Management Council Clinical Consensus Panel (2006) Alzheimer’s disease: risk stratification, patient evaluation, and outcome – effective pharmacologic therapy – year 2004 clinical update. Available at: http://www.ahcpub.com, accessed March 28, 2006
  10. American Psychiatric Association1994Diagnostic and Statistical Manual of Mental Disorders4American Psychiatric AssociationWashington, DCGoogle Scholar
  11. Arshavsky YI (2006) Alzheimer’s disease, brain immune privilege and memory: a hypothesis. J Neural Transm Epub ahead of print: DOI: 10.1007/s00702-006-0524-4Google Scholar
  12. Attems, J, Jellinger, KA, Lintner, F 2005Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathyActa Neuropathol (Berl)110222231Google Scholar
  13. Bäckman, L, Jones, S, Berger, AK, Laukka, EJ, Small, BJ 2005Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysisNeuropsychology19520531PubMedGoogle Scholar
  14. Barret, A 1913A case of Alzheimer’s disease with unusual neurological disturbancesJ Nerv Ment Dis40361374Google Scholar
  15. Beach, TG 1987The history of Alzheimer’s disease: three debatesJ Hist Med Allied Sci42327349PubMedGoogle Scholar
  16. Bennett, DA, Holtzman, DM 2005Immunization therapy for Alzheimer disease?Neurology641012PubMedGoogle Scholar
  17. Bennett, DA, Schneider, JA, Arvanitakis, Z, Kelly, JF, Aggarwal, NT, Shah, RC, Wilson, RS 2006Neuropathology of older persons without cognitive impairment from two community-based studiesNeurology6618371844PubMedGoogle Scholar
  18. Berchtold, NC, Cotman, CW 1998Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960sNeurobiol Aging19173189PubMedGoogle Scholar
  19. Bick K, Amaducci LA (1987) The early story of Alzheimer’s disease: Translation of the Historical Papers by Alois Alzheimer, Oskar Fischer, Francesco Bonfiglio, Emil Kraepelin, and Gaetano Perusini. Liviana Press, PadovaGoogle Scholar
  20. Bick, KL 1999The early story of Alzheimer diseaseTerry, RDKatzman, RBick, KLSisodia, S eds. Alzheimer Disease2Lippincott-Williams & WilkinsBaltimore110Google Scholar
  21. Birks J (2006) Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev: CD005593Google Scholar
  22. Blasko, I, Kemmler, G, Krampla, W, Jungwirth, S, Wichart, I, Jellinger, K, Tragl, KH, Fischer, P 2005Plasma amyloid beta protein 42 in non-demented persons aged 75 years: effects of concomitant medication and medial temporal lobe atrophyNeurobiol Aging2611351143PubMedGoogle Scholar
  23. Blennow, K, de Leon, MJ, Zetterberg, H 2006Alzheimer’s diseaseLancet368387403PubMedGoogle Scholar
  24. Blessed, G, Tomlinson, BE, Roth, M 1968The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjectsBr J Psychiatry114797811PubMedGoogle Scholar
  25. Blocq, P, Marinesco, G 1892Sur les lésions et la pathogénie de l’épilepsie dite essentielleSem Med12445446Google Scholar
  26. Borchelt, DR, Wong, PC, Sisodia, SS, Price, DL 1998Transgenic mouse models of Alzheimer’s disease and amyotrophic lateral sclerosisBrain Pathol8735757PubMedCrossRefGoogle Scholar
  27. Bowen, DM, Smith, CB, Davison, AN 1973Molecular changes in senile dementiaBrain96849856PubMedGoogle Scholar
  28. Boyle, PA, Wilson, RS, Aggarwal, NT, Tang, Y, Bennett, DA 2006Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive declineNeurology67441445PubMedGoogle Scholar
  29. Braak, H, Braak, E 1991Neuropathological staging of Alzheimer-related changesActa Neuropathol (Berl)82239259Google Scholar
  30. Braak, H, Alafuzoff, I, Arzberger, T, Kretzschmar, H, Del Tredici, K 2006Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryActa Neuropathol (Berl)112389404Google Scholar
  31. Castano, EM, Roher, AE, Esh, CL, Kokjohn, TA, Beach, T 2006Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer’s disease and non-demented elderly subjectsNeurol Res28155163PubMedGoogle Scholar
  32. Citron, M 2004Strategies for disease modification in Alzheimer’s diseaseNat Rev Neurosci5677685PubMedGoogle Scholar
  33. Cotman, CW, Poon, WW, Rissman, RA, Blurton-Jones, M 2005The role of caspase cleavage of tau in Alzheimer disease neuropathologyJ Neuropathol Exp Neurol64104112PubMedGoogle Scholar
  34. Coyle, JT, Price, DL, DeLong, MR 1983Alzheimer’s disease: a disorder of cortical cholinergic innervationScience21911841190PubMedGoogle Scholar
  35. Cupers, P, Sautter, J, Vanvossel, A 2006European Union research policy and funding for Alzheimer diseaseNat Med12774775PubMedGoogle Scholar
  36. Davies, P, Maloney, AJF 1976Letter to the editor: selective loss of central cholinergic neurons in Alzheimer’s diseaseLancetII1403Google Scholar
  37. de Craen, AJ, Gussekloo, J, Vrijsen, B, Westendorp, RG 2005Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementiaAm J Epidemiol161114120PubMedGoogle Scholar
  38. Delacourte, A, David, JP, Sergeant, N, Buee, L, Wattez, A, Vermersch, P, Ghozali, F, Fallet-Bianco, C, Pasquier, F, Lebert, F, Petit, H, Di Menza, C 1999The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s diseaseNeurology5211581165PubMedGoogle Scholar
  39. Delacourte, A, Sergeant, N, Champain, D, Wattez, A, Maurage, CA, Lebert, F, Pasquier, F, David, JP 2002Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s diseaseNeurology59398407PubMedGoogle Scholar
  40. Delacourte, A 2005Alzheimer’s disease: a true tauopathy fueled by amyloid precursor protein dysfunctionHanin, ICacabelos, RFisher, A eds. Recent Progress in Alzheimer’s and Parkinson’s DiseasesTaylor & FrancisNew York301307Google Scholar
  41. Divry, P 1927Étude histochemique des plaques sénilesJ Belg Neur Psychiatr27643657Google Scholar
  42. Drachman, DA, Ommaya, AK 1964Memory and the Hippocampal ComplexArch Neurol10411425PubMedGoogle Scholar
  43. Duyckaerts, C, Dickson, DW 2003Neuropathology of Alzheimer’s diseaseDickson, DW eds. NeurodegenerationISN Neuropath PressBasel4765Google Scholar
  44. Engelborghs, S, De Vreese, K, Van de Casteele, T, Vanderstichele, H, Van Everbroeck, B, Cras, P, Martin, JJ, Vanmechelen, E, De Deyn, PP 2006Evaluation of a CSF-biomarker panel in autopsy-confirmed dementia (Abstr)Eur J Neurol1331Google Scholar
  45. Ferrer, I, Boada Rovira, M, Sanchez Guerra, ML, Rey, MJ, Costa-Jussa, F 2004Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer’s diseaseBrain Pathol141120PubMedCrossRefGoogle Scholar
  46. Ferri, CP, Prince, M, Brayne, C, Brodaty, H, Fratiglioni, L, Ganguli, M, Hall, K, Hasegawa, K, Hendrie, H, Huang, Y, Jorm, A, Mathers, C, Menezes, PR, Rimmer, E, Scazufca, M 2005Global prevalence of dementia: a Delphi consensus studyLancet36621122117PubMedGoogle Scholar
  47. Fischer, O 1907Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler DemenzMonat Psychiatr Neurol22361372Google Scholar
  48. Flirski, M, Sobow, T 2005Biochemical markers and risk factors of Alzheimer’s diseaseCurr Alzheimer Res24764PubMedGoogle Scholar
  49. Francis, PT, Palmer, AM, Snape, M, Wilcock, GK 1999The cholinergic hypothesis of Alzheimer’s disease: a review of progressJ Neurol Neurosurg Psychiatry66137147PubMedGoogle Scholar
  50. Fuller, S 1912Alzheimer’s disease (senium praecox): The report of a case and review of published casesJ Nerv Ment Dis440–455536557Google Scholar
  51. Galvin, JE, Powlishta, KK, Wilkins, K, McKeel, DW,Jr, Xiong, C, Grant, E, Storandt, M, Morris, JC 2005Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic studyArch Neurol62758765PubMedGoogle Scholar
  52. Games, D, Buttini, M, Kobayashi, D, Schenk, D, Seubert, P 2006Mice as models: Transgenic approaches and Alzheimer’s diseaseJ Alzheimers Dis9133149PubMedGoogle Scholar
  53. Gauthier, SG 2005Alzheimer’s disease: the benefits of early treatmentEur J Neurol121116PubMedGoogle Scholar
  54. Gellerstedt, N 1933Zur Kenntnis der Hirnveränderungen bei der normalen AltersinvolutionUpsala Läk-Fören Förh38193408Google Scholar
  55. Glenner, GG, Wong, CW 1984Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochem Biophys Res Commun120885890PubMedGoogle Scholar
  56. Goldgaber, D 2006My story: the discovery and mapping to chromosome 21 of the Alzheimer amyloid geneJ Alzheimers Dis9349360PubMedGoogle Scholar
  57. Graeber, MB, Kosel, S, Egensperger, R, Banati, RB, Muller, U, Bise, K, Hoff, P, Moller, HJ, Fujisawa, K, Mehraein, P 1997Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysisNeurogenetics17380PubMedGoogle Scholar
  58. Graeber, MB, Mehraein, P 1999Reanalysis of the first case of Alzheimer’s diseaseEur Arch Psychiatry Clin Neurosci2491013PubMedGoogle Scholar
  59. Graeber MB (2006) Alois Alzheimer (1864–1915). Internet http://www.ibro.info/Pub_Main_Display.asp?Main_Id=34
  60. Grundke-Iqbal, I, Iqbal, K, Quinlan, M, Tung, YC, Zaidi, MS, Wisniewski, HM 1986Microtubule-associated protein tau. A component of Alzheimer paired helical filamentsJ Biol Chem26160846089PubMedGoogle Scholar
  61. Grünthal, E 1926Über die Alzheimerische Krankheit: Eine histopathologisch-klinische StudieZ Gesamte Neurol Psychiatr101129157Google Scholar
  62. Guillozet, AL, Weintraub, S, Mash, DC, Mesulam, MM 2003Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairmentArch Neurol60729736PubMedGoogle Scholar
  63. Haass, C, Schlossmacher, MG, Hung, AY, Vigo-Pelfrey, C, Mellon, A, Ostaszewski, BL, Lieberburg, I, Koo, EH, Schenk, D, Teplow, DB,  et al. 1992Amyloid beta-peptide is produced by cultured cells during normal metabolismNature359322325PubMedGoogle Scholar
  64. Hampel, H, Mitchell, A, Blennow, K, Frank, RA, Brettschneider, S, Weller, L, Moller, HJ 2004Core biological marker candidates of Alzheimer’s disease – perspectives for diagnosis, prediction of outcome and reflection of biological activityJ Neural Transm111247272PubMedGoogle Scholar
  65. Hansen, L, Salmon, D, Galasko, D, Masliah, E, Katzman, R, DeTeresa, R, Thal, L, Pay, MM, Hofstetter, R, Klauber, M,  et al. 1990The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entityNeurology4018PubMedGoogle Scholar
  66. Hardy, J 2004Genetics of Alzheimer’s disease and related disordersRichter, RWZoeller-Richter, B eds. Current clinical neurologyHumana Press Inc.Totowa, NJ320Google Scholar
  67. Hardy, JA, Higgins, GA 1992Alzheimer’s disease: the amyloid cascade hypothesisScience256184185PubMedGoogle Scholar
  68. Hardy, J, Cullen, K 2006Amyloid at the blood vessel wallNat Med12756757PubMedGoogle Scholar
  69. Herholz, KPerani, DMorris, JC eds. 2006The Dementias: Early Diagnosis and EvaluationTaylor & FrancisNew YorkGoogle Scholar
  70. Heston, LL, Mastri, AR 1977The genetics of Alzheimer’s disease: associations with hematologic malignancy and Down’s syndromeArch Gen Psychiatry34976981PubMedGoogle Scholar
  71. Hock, C, Konietzko, U, Streffer, JR, Tracy, J, Signorell, A, Muller-Tillmanns, B, Lemke, U, Henke, K, Moritz, E, Garcia, E, Wollmer, MA, Umbricht, D, de Quervain, DJ, Hofmann, M, Maddalena, A, Papassotiropoulos, A, Nitsch, RM 2003Antibodies against beta-amyloid slow cognitive decline in Alzheimer’s diseaseNeuron38547554PubMedGoogle Scholar
  72. Hodes, RJ 2006Public funding for Alzheimer disease research in the United StatesNat Med12770773PubMedGoogle Scholar
  73. Hyman, BT, Van Hoesen, GW, Damasio, AR, Barnes, CL 1984Alzheimer’s disease: cell-specific pathology isolates the hippocampal formationScience22511681170PubMedGoogle Scholar
  74. Hyman, BT, Trojanowski, JQ 1997Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer diseaseJ Neuropathol Exp Neurol5610951097PubMedGoogle Scholar
  75. Hyman, BT, Growdon, JH 2006Can the immune system fight Alzheimer disease?Nat Med12755756discussion 756PubMedGoogle Scholar
  76. Iqbal, K, Flory, M, Khatoon, S, Soininen, H, Pirttila, T, Lehtovirta, M, Alafuzoff, I, Blennow, K, Andreasen, N, Vanmechelen, E, Grundke-Iqbal, I 2005Subgroups of Alzheimer’s disease based on cerebrospinal fluid molecular markersAnn Neurol58748757PubMedGoogle Scholar
  77. Iqbal, K, Grundke-Iqbal, I 2006Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: A personal historical perspectiveJ Alzheimers Dis9219242PubMedGoogle Scholar
  78. Irizarry, MC 2004Biomarkers of Alzheimer disease in plasmaNeuroRx1226234PubMedGoogle Scholar
  79. Iwatsubo, T, Ihara, Y, Kanazawa, I 2006Alzheimer disease research in Japan: public fundingNat Med12778779PubMedGoogle Scholar
  80. Jagust, W, Gitcho, A, Sun, F, Kuczynski, B, Mungas, D, Haan, M 2006Brain imaging evidence of preclinical Alzheimer’s disease in normal agingAnn Neurol59673681PubMedGoogle Scholar
  81. Jelic, V, Kivipelto, M, Winblad, B 2006Clinical trials in mild cognitive impairment: lessons for the futureJ Neurol Neurosurg Psychiatry77429438PubMedGoogle Scholar
  82. Jellinger KA (2003a) Neuropathology of Alzheimer disease and clinical relevance. In: Iqbal K, Winblad B (eds) Alzheimer’s disease and related disorders: research advances. Ana Aslan Intl Acad. Aging Bucharest, Romania, pp 153–169Google Scholar
  83. Jellinger, KA 2003bPlaque-predominant and tangle-predominant variants of Alzheimer’s diseaseDickson, DW eds. Neurodegeneration: the molecular pathology of dementia and movement disordersISN Neuropath PressBasel6668Google Scholar
  84. Jellinger, KA 2004Pathology and pathophysiology of vascular cognitive impairment. A critical updatePanminerva Med46217226PubMedGoogle Scholar
  85. Jellinger, KA 2005Understanding the pathology of vascular cognitive impairmentJ Neurol Sci229–2305763PubMedGoogle Scholar
  86. Jellinger, KA 2006aA view on early diagnosis of dementias from neuropathologyHerholz, KMorris, CPerani, D eds. The Dementias: early diagnosis and evaluationTaylor & FrancisNew York311428Google Scholar
  87. Jellinger KA (2006b) Alzheimer: Meilensteine aus hundert Jahren wissenschaftlicher und klinischer Forschung. AKA, BerlinGoogle Scholar
  88. Jellinger KA (2006c) The enigma of mixed dementia. Alzheimer’s & Dementia (in press)Google Scholar
  89. Jervis, GA, Soltz, SE 1936Alzheimer’s disease: The so-called juvenile formAm J Psychiatr933956Google Scholar
  90. Jönssön, L, Berr, C 2005Cost of dementia in EuropeEur J Neurol125053PubMedGoogle Scholar
  91. Jucker, MBeyreuther, KHaass, CNitsch, RMChristen, Y eds. 2006Alzheimer: 100 years and beyondSpringerBerlin Heidelberg New YorkGoogle Scholar
  92. Kaduszkiewicz, H, Zimmermann, T, Beck-Bornholdt, HP, van den Bussche, H 2005Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trialsBMJ331321327PubMedGoogle Scholar
  93. Katsuno, T, Morishima-Kawashima, M, Saito, Y, Yamanouchi, H, Ishiura, S, Murayama, S, Ihara, Y 2005Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortexNeurology64687692PubMedGoogle Scholar
  94. Katzman, R 1976Editorial: The prevalence and malignancy of Alzheimer disease. A major killerArch Neurol33217218PubMedGoogle Scholar
  95. Katzman, R, Bick, K 2000Alzheimer disease. The changing viewAcademic PressSan DiegoGoogle Scholar
  96. Khachaturian, ZS 1985Diagnosis of Alzheimer’s diseaseArch Neurol4210971105PubMedGoogle Scholar
  97. Khachaturian, ZS 2005Diagnosis of Alzheimer’s disease: two decades of progressAlzheimers Dementia19398Google Scholar
  98. Khachaturian, ZS 2006Diagnosis of Alzheimer’s disease: two-decades of progressJ Alzheimers Dis9409415PubMedGoogle Scholar
  99. Kidd, M 1963Paired helical filaments in electron microscopy of Alzheimer’s diseaseNature197192193PubMedGoogle Scholar
  100. Kidd, M 2006The history of the paired helical filamentsJ Alzheimers Dis97175PubMedGoogle Scholar
  101. Kins, S, Beyreuther, K 2006Teasing out the tanglesNat Med12764765discussion 765PubMedGoogle Scholar
  102. Klünemann, HH, Fronhofer, W, Wurster, H, Fischer, W, Ibach, B, Klein, HE 2002Alzheimer’s second patient: Johann F. and his familyAnn Neurol52520523PubMedGoogle Scholar
  103. Klunk, WE, Engler, H, Nordberg, A, Wang, Y, Blomqvist, G, Holt, DP, Bergstrom, M, Savitcheva, I, Huang, GF, Estrada, S, Ausen, B, Debnath, ML, Barletta, J, Price, JC, Sandell, J, Lopresti, BJ, Wall, A, Koivisto, P, Antoni, G, Mathis, CA, Langstrom, B 2004Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-BAnn Neurol55306319PubMedGoogle Scholar
  104. Knopman, DS, Parisi, JE, Salviati, A, Floriach-Robert, M, Boeve, BF, Ivnik, RJ, Smith, GE, Dickson, DW, Johnson, KA, Petersen, LE, McDonald, WC, Braak, H, Petersen, RC 2003Neuropathology of cognitively normal elderlyJ Neuropathol Exp Neurol6210871095PubMedGoogle Scholar
  105. Kraepelin, E 1910Psychiatrie: ein Lehrbuch für Studierende und Ärzte. II. Band, Klinische PsychiatrieVerlag Johann Ambrosius BarthLeipzigGoogle Scholar
  106. Kurz, A, Diehl, J, Riemenschneider, M, Perneczky, R, Lautenschlager, N 2004[Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy]Nervenarzt75615PubMedGoogle Scholar
  107. Lage, JMM 2006100 years of Alzheimer’s disease (1906–2006)J Alzheimers Dis91526PubMedGoogle Scholar
  108. Lesne, S, Koh, MT, Kotilinek, L, Kayed, R, Glabe, CG, Yang, A, Gallagher, M, Ashe, KH 2006A specific amyloid-beta protein assembly in the brain impairs memoryNature440352357PubMedGoogle Scholar
  109. Lleo, A, Greenberg, SM, Growdon, JH 2006Current pharmacotherapy for Alzheimer’s diseaseAnnu Rev Med57513533PubMedGoogle Scholar
  110. Malamud, W, Lowenberg, K 1929Alzheimer’s disease: a contribution to its etiology and classificationArch Neurol Psychiat21805827Google Scholar
  111. Mandavilli, A 2006The amyloid codeNat Med12747751PubMedGoogle Scholar
  112. Markesbery, WR, Schmitt, FA, Kryscio, RJ, Davis, DG, Smith, CD, Wekstein, DR 2006Neuropathologic substrate of mild cognitive impairmentArch Neurol633846PubMedGoogle Scholar
  113. Masters, CL, Simms, G, Weinman, NA, Multhaup, G, McDonald, BL, Beyreuther, K 1985Amyloid plaque core protein in Alzheimer disease and Down syndromeProc Natl Acad Sci USA8242454249PubMedGoogle Scholar
  114. Masters, CL, Beyreuther, K 2006Pathways to the discovery of the Aβ amyloid of Alzheimer’s diseaseJ Alzheimers Dis9155161PubMedGoogle Scholar
  115. Maurer, K, Volk, S, Gerbaldo, H 1997Auguste D and Alzheimer’s diseaseLancet34915461549PubMedGoogle Scholar
  116. Maurer, K, Maurer, U 2003Alzheimer: The life of a physician and the career of a diseaseColumbia Univ PressNew YorkGoogle Scholar
  117. Maurer, U, Maurer, K 1999Auf den Spuren der Auguste D. Alois Alzheimer – Sein Leben und WerkForschung Frankfurt47477Google Scholar
  118. McKeith, IG, Dickson, DW, Lowe, J, Emre, M, O’Brien, JT, Feldman, H, Cummings, J, Duda, JE, Lippa, C, Perry, EK, Aarsland, D, Arai, H, Ballard, CG, Boeve, B, Burn, DJ, Costa, D, Del Ser, T, Dubois, B, Galasko, D, Gauthier, S, Goetz, CG, Gomez-Tortosa, E, Halliday, G, Hansen, LA, Hardy, J, Iwatsubo, T, Kalaria, RN, Kaufer, D, Kenny, RA, Korczyn, A, Kosaka, K, Lee, VM, Lees, A, Litvan, I, Londos, E, Lopez, OL, Minoshima, S, Mizuno, Y, Molina, JA, Mukaetova-Ladinska, EB, Pasquier, F, Perry, RH, Schulz, JB, Trojanowski, JQ, Yamada, M 2005Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumNeurology6518631872PubMedGoogle Scholar
  119. McKhann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM 1984Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology34939944PubMedGoogle Scholar
  120. McShane R, Areosa Sastre A, Minakaran N (2006) Memantine for dementia. Cochrane Database Syst Rev: CD003154Google Scholar
  121. Meyer, JE 1961Alois AlzheimerScholz, W eds. 50 Jahre Neuropathologie in Deutschland (1885–1935)ThiemeStuttgart6778Google Scholar
  122. Mintun, MA, Larossa, GN, Sheline, YI, Dence, CS, Lee, SY, Mach, RH, Klunk, WE, Mathis, CA, DeKosky, ST, Morris, JC 2006[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer diseaseNeurology67446452PubMedGoogle Scholar
  123. Mirra, SS, Heyman, A, McKeel, D, Sumi, SM, Crain, BJ, Brownlee, LM, Vogel, FS, Hughes, JP, van Belle, G, Berg, L 1991The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s diseaseNeurology41479486PubMedGoogle Scholar
  124. Möller, HJ, Graeber, MB 1998The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sectionsEur Arch Psychiatry Clin Neurosci248111122PubMedGoogle Scholar
  125. Morgan, D 2006Immunotherapy for Alzheimer’s diseaseJ Alzheimers Dis9425432PubMedGoogle Scholar
  126. Morris, JH, Nagy, Z 2004Alzheimer’s diseaseEsiri, MLee, VMYTrojanowski, JQ eds. The neuropathology of dementiaCambridge University PressCambridge161206Google Scholar
  127. Mott, RT, Dickson, DW, Trojanowski, JQ, Zhukareva, V, Lee, VM, Forman, M, Van Deerlin, V, Ervin, JF, Wang, DS, Schmechel, DE, Hulette, CM 2005Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementiasJ Neuropathol Exp Neurol64420428PubMedGoogle Scholar
  128. Mount, C, Downton, C 2006Alzheimer disease: progress or profit?Nat Med12780784PubMedGoogle Scholar
  129. Mrak, RE 2002The Big Eye in the 21st century: the role of electron microscopy in modern diagnostic neuropathologyJ Neuropathol Exp Neurol6110271039PubMedGoogle Scholar
  130. Mueller, SG, Weiner, MW, Thal, LJ, Petersen, RC, Jack, CR, Jagust, W, Trojanowski, JQ, Toga, AW, Beckett, L 2005Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI)Alzheimer Dementia15566Google Scholar
  131. Munoz, DG, Dickson, DW, Bergeron, C, Mackenzie, IR, Delacourte, A, Zhukareva, V 2003The neuropathology and biochemistry of frontotemporal dementiaAnn Neurol54S24S28PubMedGoogle Scholar
  132. Neumann, MA, Cohn, R 1953Incidence of Alzheimer’s disease in large mental hospital; relation to senile psychosis and psychosis with cerebral arteriosclerosisAMA Arch Neurol Psychiatry69615636PubMedGoogle Scholar
  133. Neundörfer G, Hippius H (2003) Historischer Hintergrund der Alzheimer-Demenz. Alois Alzheimer – sein Name im Kontext der Erkrankung. In: Hampel H, Padberg F, Moeller HJ (eds) Alzheimer-Demenz. Klinische Verläufe, diagnostische Möglichkeiten, moderne Therapiestrategien. Wissenschaftliche Verlagsges. Stuttgart, pp 1–13Google Scholar
  134. Newton RD (1948) The identity of Alzheimer’s disease and senile dementia and their relationship to senility. J Ment Sci: 225–248Google Scholar
  135. Nicoll, JA, Wilkinson, D, Holmes, C, Steart, P, Markham, H, Weller, RO 2003Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case reportNat Med9448452PubMedGoogle Scholar
  136. O’Brien, JMcKeith, IGAmes, DChiu, E eds. 2006Dementia with Lewy Bodies and Parkinson’s Disease DementiaTaylor & FrancisNew YorkGoogle Scholar
  137. Orgogozo, JM, Gilman, S, Dartigues, JF, Laurent, B, Puel, M, Kirby, LC, Jouanny, P, Dubois, B, Eisner, L, Flitman, S, Michel, BF, Boada, M, Frank, A, Hock, C 2003Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunizationNeurology614654PubMedGoogle Scholar
  138. Pantelakis, S 1954(A particular type of senile angiopathy of the central nervous system: congophilic angiopathy, topography and frequency.)Monatsschr Psychiatr Neurol128219256PubMedGoogle Scholar
  139. Perry, EK, Tomlinson, BE, Blessed, G, Bergmann, K, Gibson, PH, Perry, RH 1978Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementiaBr Med J214571459PubMedCrossRefGoogle Scholar
  140. Perusini, G 1910Über klinisch und histologisch eigenartige psychische Erkrankungen des späteren LebensaltersNissl, FAlzheimer, A eds. Histologische und histopathologische ArbeitenFischerJenaGoogle Scholar
  141. Petersen, RC eds. 2003Mild Cognitive Impairment: Aging to Alzheimer’s DiseaseOxford University PressOxfordGoogle Scholar
  142. Petersen, RC, Thomas, RG, Grundman, M, Bennett, D, Doody, R, Ferris, S, Galasko, D, Jin, S, Kaye, J, Levey, A, Pfeiffer, E, Sano, M, van Dyck, CH, Thal, LJ 2005Vitamin E and donepezil for the treatment of mild cognitive impairmentN Engl J Med35223792388PubMedGoogle Scholar
  143. Pickett, W 1904Senile dementia: a clinical study of two hundred cases with particular regard to types of the diseaseJ Nerv Ment Dis318188CrossRefGoogle Scholar
  144. Portet, F, Ousset, PJ, Visser, PJ, Frisoni, GB, Nobili, F, Scheltens, P, Vellas, B, Touchon, J 2006Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s DiseaseJ Neurol Neurosurg Psychiatry77714718PubMedGoogle Scholar
  145. Redlich, E 1898über miliare Sklerosen der hirnrinde bei seniler AtrophieJahrb Psychiatr Neurol17208216Google Scholar
  146. Riley, KP, Snowdon, DA, Markesbery, WR 2002Alzheimer’s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun StudyAnn Neurol51567577PubMedGoogle Scholar
  147. Román, GC, Tatemichi, TK, Erkinjuntti, T, Cummings, JL, Masdeu, JC, Garcia, JH, Amaducci, L, Orgogozo, JM, Brun, A, Hofman, A,  et al. 1993Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International WorkshopNeurology43250260PubMedCrossRefGoogle Scholar
  148. Rosen, WG, Mohs, RC, Davis, KL 1984A new rating scale for Alzheimer’s diseaseAm J Psychiatry14113561364PubMedGoogle Scholar
  149. Roses, AD 2006On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer diseaseJ Alzheimers Dis9361366PubMedGoogle Scholar
  150. Rothschild, D 1937Pathologic changes in senile psychoses and their psychobiologic significanceAm J Psychiatr93757788Google Scholar
  151. Rothschild, D 1941Clinical differentiation of senile and ateriosclerotic psychosesAm J Psychiatr98324333Google Scholar
  152. Salkovic-Petrisic, M, Tribl, F, Schmidt, M, Hoyer, S, Riederer, P 2006Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathwayJ Neurochem9610051015PubMedGoogle Scholar
  153. Scheff, SW, DeKosky, ST, Price, DA 1990Quantitative assessment of cortical synaptic density in Alzheimer’s diseaseNeurobiol Aging112937PubMedGoogle Scholar
  154. Scheff, SW, Price, DA 2003Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studiesNeurobiol Aging2410291046PubMedGoogle Scholar
  155. Scheff, SW, Price, DA 2006Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampusJ Alzheimers Dis9101115PubMedGoogle Scholar
  156. Scheff, SW, Price, DA, Schmitt, FA, Mufson, EJ 2006Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairmentNeurobiol Aging2713721384PubMedGoogle Scholar
  157. Schellenberg, GD 2006Early Alzheimer’s disease geneticsJ Alzheimers Dis9367372PubMedGoogle Scholar
  158. Schenk, D, Barbour, R, Dunn, W, Gordon, G, Grajeda, H, Guido, T, Hu, K, Huang, J, Johnson-Wood, K, Khan, K, Kholodenko, D, Lee, M, Liao, Z, Lieberburg, I, Motter, R, Mutter, L, Soriano, F, Shopp, G, Vasquez, N, Vandevert, C, Walker, S, Wogulis, M, Yednock, T, Games, D, Seubert, P 1999Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature400173177PubMedGoogle Scholar
  159. Selkoe, DJ 2006aAmyloid beta-peptide is produced by cultured cells during normal metabolism: a repriseJ Alzheimers Dis9163168Google Scholar
  160. Selkoe, DJ 2006bThe ups and downs of AbetaNat Med12758759discussion 759Google Scholar
  161. Shumaker, SA, Legault, C, Rapp, SR, Thal, L, Wallace, RB, Ockene, JK, Hendrix, SL, Jones, BN,3rd, Assaf, AR, Jackson, RD, Kotchen, JM, Wassertheil-Smoller, S, Wactawski-Wende, J 2003Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trialJAMA28926512662PubMedGoogle Scholar
  162. Simchowitz, T 1911Histologische Studien über die senile DemenzNissl, FAlzheimer, A eds. Histologische und histopathologische ArbeitenFischerJena267444Google Scholar
  163. Spielmeyer, W 1916Alzheimers LebenswerkZ Gesamte Neurol Psychiatr33144Google Scholar
  164. Storandt, M, Grant, EA, Miller, JP, Morris, JC 2006Longitudinal course and neuropathologic outcomes in original vs. revised MCI and in pre-MCINeurology67467473PubMedGoogle Scholar
  165. Terry, RD 1963The fine structure of neurofibrillary tangles in Alzheimer’s diseaseJ Neuropathol Exp Neurol22629642PubMedGoogle Scholar
  166. Terry, RD, Gonatas, NK, Weiss, M 1964Ultrastructural studies in Alzheimer’s presenile dementiaAm J Pathol44269297PubMedGoogle Scholar
  167. Terry, RD, Masliah, E, Salmon, DP, Butters, N, DeTeresa, R, Hill, R, Hansen, LA, Katzman, R 1991Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairmentAnn Neurol30572580PubMedGoogle Scholar
  168. Thal, DR, Rub, U, Orantes, M, Braak, H 2002Phases of A beta-deposition in the human brain and its relevance for the development of ADNeurology5817911800PubMedGoogle Scholar
  169. Thal, LJ, Kantarci, K, Reiman, EM, Klunk, WE, Weiner, MW, Zetterberg, H, Galasko, D, Pratico, D, Griffin, S, Schenk, D, Siemers, E 2006The role of biomarkers in clinical trials for Alzheimer diseaseAlzheimer Dis Assoc Disord20615PubMedGoogle Scholar
  170. The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group1998Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Neurobiol Aging19109116Google Scholar
  171. Tian, J, Shi, J, Mann, DM 2004Cerebral amyloid angiopathy and dementiaPanminerva Med46253264PubMedGoogle Scholar
  172. Tiraboschi, P, Sabbagh, MN, Hansen, LA, Salmon, DP, Merdes, A, Gamst, A, Masliah, E, Alford, M, Thal, LJ, Corey-Bloom, J 2004Alzheimer disease without neocortical neurofibrillary tangles: “a second look”Neurology6211411147PubMedGoogle Scholar
  173. Tomlinson, BE, Blessed, G, Roth, M 1970Observations on the brains of demented old peopleJ Neurol Sci11205242PubMedGoogle Scholar
  174. Trojanowski, JQ, Dickson, D 2001Update on the neuropathological diagnosis of frontotemporal dementiasJ Neuropathol Exp Neurol6011231126PubMedGoogle Scholar
  175. Tschanz, JT, Welsh-Bohmer, KA, Lyketsos, CG, Corcoran, C, Green, RC, Hayden, K, Norton, MC, Zandi, PP, Toone, L, West, NA, Breitner, JC 2006Conversion to dementia from mild cognitive disorder: the Cache County StudyNeurology67229234PubMedGoogle Scholar
  176. Uyehara-Lock, JH, Petrovich, H, Ross, GW, Masaki, KH, Davis, DG, Hardman, JM, Nelson, J, Markesbery, WR, White, LR 2005A comparison of Braak staging with CERAD criteria for the neuropahtologic assessment of dementiaAnn Neurol58S56Google Scholar
  177. van der Flier, WM, Scheltens, P 2005Epidemiology and risk factors of dementiaJ Neurol Neurosurg Psychiatry76v2v7PubMedGoogle Scholar
  178. van Oijen, M, Hofman, A, Soares, HD, Koudstaal, PJ, Breteler, MM 2006Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort studyLancet Neurol5655660PubMedGoogle Scholar
  179. Vanderstichele, H, De Meyer, G, Andreasen, N, Kostanjevecki, V, Wallin, A, Olsson, A, Blennow, K, Vanmechelen, E 2005Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairmentClin Chem5116501660PubMedGoogle Scholar
  180. Vinters, HV 1987Cerebral amyloid angiopathy. A critical reviewStroke18311324PubMedGoogle Scholar
  181. Weller, RO, Massey, A, Newman, TA, Hutchings, M, Kuo, YM, Roher, AE 1998Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer’s diseaseAm J Pathol153725733PubMedGoogle Scholar
  182. West, MJ, Kawas, CH, Stewart, WF, Rudow, GL, Troncoso, JC 2004Hippocampal neurons in pre-clinical Alzheimer’s diseaseNeurobiol Aging2512051212PubMedGoogle Scholar
  183. Wiltfang, J, Lewczuk, P, Riederer, P, Grunblatt, E, Hock, C, Scheltens, P, Hampel, H, Vanderstichele, H, Iqbal, K, Galasko, D, Lannfelt, L, Otto, M, Esselmann, H, Henkel, AW, Kornhuber, J, Blennow, K 2005Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementiaWorld J Biol Psychiatry66984PubMedGoogle Scholar
  184. Wimo, A, Jonsson, L, Winblad, B 2006An estimate of the worldwide prevalence and direct costs of dementia in 2003Dement Geriatr Cogn Disord21175181PubMedGoogle Scholar
  185. Winblad, B, Wimo, A 2006The worldwide direct costs and costs of informal care of dementiaAlzheimer Dementia2S19Google Scholar
  186. Wisniewski, HM, Iqbal, K 1980Aging of the brain and dementiaTrends Neurosci3226228Google Scholar
  187. Wisniewski, HM, Robe, A, Zigman, W, Silverman, W 1989Neuropathological diagnosis of Alzheimer diseaseJ Neuropathol Exp Neurol48606609PubMedCrossRefGoogle Scholar
  188. World Health Organization (1993) ICD-10 Classification of mental and behavioural disorders: diagnostic criteria for research. WHO GenevaGoogle Scholar
  189. Yaffe, K, Petersen, RC, Lindquist, K, Kramer, J, Miller, B 2006Subtype of mild cognitive impairment and progression to dementia and deathDement Geriatr Cogn Disord22312319PubMedGoogle Scholar
  190. Ziolko, SK, Weissfeld, LA, Klunk, WE, Mathis, CA, Hoge, JA, Lopresti, BJ, Dekosky, ST, Price, JC 2006Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer’s diseaseNeuroimage3394102PubMedGoogle Scholar
  191. Zlokovic, BV 2005Neurovascular mechanisms of Alzheimer’s neurodegenerationTrends Neurosci28202208PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • K. A. Jellinger
    • 1
  1. 1.Institute of Clinical NeurobiologyViennaAustria

Personalised recommendations